EUVIMEDEUVIMED entdecken
Crossref

Thalassemia Major: Outcomes and Complications: A Retrospective Analysis of Thalassemia Major Cases, Including Outcomes and Complications

Jitendra Kumar, Amit Chaubey, Manoj Kumar Singh

International Journal of Current Pharmaceutical Review and Research · 30.05.2026 · 18 (05)

DOI: 10.25258/ijcpr.18.5.60 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.05.2026. Verfasst von Jitendra Kumar und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Thalassemia major is a serious hereditary hemoglobinopathy, which necessitates lifelong blood transfusions and chelation therapy. Despite advances in therapy, there remains substantial morbidity from iron overload and multisystem disease in patients particularly limited by resource. Data from Eastern India are infrequent.

Methods

A record based retrospective observational study was conducted at Patna Medical College & Hospital (PMCH), Patna from February 2025 to July 2025. The medical charts of patients with proven thalassemia major attending OPD or IPD were studied. Information collected included demographic data, age at diagnosis, transfusion rate, serum ferritin levels, compliance with chelation therapy (CT), the complications and clinical outcome. Descriptive statistics were utilized for the data analyses with SPSS.

Results

A total of 72 patients were enrolled, and the mean age was 9.8 ± 4.2 years; there were more male than female. A high percentage of patients required transfusion maintenance every 3 to 4 weeks, and most had their first transfusion prior to the age of one year. Suboptimal or intermittent chelation adherence was recorded in a significant proportion of patients. Frequent complications were iron overload–associated organ damage, recurrent infections, growth delay, liver disease, endocrinopathies and cardiac involvement. Most patients had regular follow-up during the study period; documented mortality was primarily associated with cardiac complications and severe infections.

Conclusion

Thalassemia major is still burdened by many complications even with regular transfusion. The early discovery, strict chelation adherence and long-term follow-up are necessary for better prognosis. Local data like this study can help in reinforcing control programs for thalassemia in Eastern India.

Zitieren

APA

Kumar, J., Chaubey, A., & Singh, M. K. (2026). Thalassemia Major: Outcomes and Complications: A Retrospective Analysis of Thalassemia Major Cases, Including Outcomes and Complications. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.60

Vancouver

Kumar J, Chaubey A, Singh MK. Thalassemia Major: Outcomes and Complications: A Retrospective Analysis of Thalassemia Major Cases, Including Outcomes and Complications. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.60

BibTeX
@article{Kumar2026,
  author = {Kumar, Jitendra and Chaubey, Amit and Singh, Manoj Kumar},
  title = {Thalassemia Major: Outcomes and Complications: A Retrospective Analysis of Thalassemia Major Cases, Including Outcomes and Complications},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {05},
  doi = {10.25258/ijcpr.18.5.60}
}
Kostenlos starten →